AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

C-RAD

Board/Management Information Mar 4, 2019

3148_iss_2019-03-04_7e671a90-9f7d-4140-b45e-a3b7e77b65d2.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

Press release 2019-03-04

C-RAD has appointed Therése Björklund as Interim CFO

C-RAD today announces that Therese Björklund has been appointed Interim Chief Financial Officer with immediate effect, succeeding Cecilia Danckwardt-Lillieström. Therése has been the CFO for C-RAD until October 15, 2018. The recruitment process for a new CFO will be started immediately.

"I want to take the opportunity to thank Cecilia for the work she did for C-RAD. I wish her all the best and a lot of success for the future." says Tim Thurn, CEO C-RAD AB.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit http://www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email [email protected]

This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 17:30 CET on March 4, 2019.

Talk to a Data Expert

Have a question? We'll get back to you promptly.